US lawyer’s confusion about Aussie patent law can’t save Sanofi unit’s application

Intellectual Property 2024-01-10 2:24 pm By Sam Matthews | Melbourne

A Sanofi unit has lost its bid for more time to file a divisional application in relation to a hemophilia treatment, with an IP Australia delegate finding that a US lawyer’s mistaken belief about Australian patent law did not explain the company’s failure to make the application in time.